Abstract:Amyloid β protein (Aβ) deposition has been implicated as the molecular driver of Alzheimer's disease (AD) progression. The modulation of the formation of abnormal aggregates and their post-translational modification is strongly suggested as the most effective approach to anti-AD. Beta-site APP-cleaving enzyme 1 (BACE1) acts upstream in amyloidogenic processing to generate Aβ, which rapidly aggregates alone or in combination with acetylcholinesterase (AChE) to form fibrils. Accumulated Aβ promotes BACE1 activation via glycogen synthase kinase-3β (GSK-3β) and is post-translationally modified by glutaminyl cyclase (QC), resulting in increased neurotoxicity. A novel multi-target inhibitor as a potential AD agent was identified using an in silico approach and experimental validation. Magnolia officinalis, which showed the best anti-AD activity in our preliminary study, was subjected to analysis, and 82 compounds were studied. Among 23 compounds with drug-likeness, blood–brain barrier penetration, and safety, honokiol emerged as a lead structure for the inhibition of BACE1, AChE, QC, and GSK-3β in docking and molecular dynamics (MD) simulations. Furthermore, honokiol was found to be an excellent multi-target inhibitor of these enzymes with an IC50 of 6–90 μM, even when compared to other natural single-target inhibitors. Taken together, the present study is the first to demonstrate that honokiol acts as a multiple enzyme inhibitor with an excellent pharmacokinetic and safety profile which may provide inhibitory effects in broad-range areas including the overproduction, aggregation, and post-translational modification of Aβ. It also provides insight into novel structural features for the design and discovery of multi-target inhibitors for anti-AD.

Monoterpenoid indole alkaloid dimers from Kopsia arborea inhibit cyclin-dependent kinase 5 and tau phosphorylation

A Cytotoxic Indole Characterized by Incorporation of a Unique Carbon-Nitrogen Skeleton and Two Pentacyclic Corynanthean Alkaloids Incorporating a Substituted Tetrahydrofuranone Ring from Kopsia arborea

Kadcotriones A-C: Tricyclic Triterpenoids from Kadsura Coccinea.

Cytotoxic monoterpenoid indole alkaloids from the aerial parts of <i>Kopsia officinalis</i>

Lanostane-type Triterpenoids from Kadsura Coccinea

Kadcoccitones A and B, Two New 6/6/5/5-Fused Tetracyclic Triterpenoids from Kadsura Coccinea

Neolignans and amide alkaloids from the stems of Piper kadsura and their neuroprotective activity

Alokicenones A-H, Eight Tetrahydroanthracenes from the Mangrove-Derived Streptomyces Sp. HN-A101

Dibenzocyclooctadiene lignans from Kadsura polysperma and their antineurodegenerative activities

Chemodiverse monoterpene indole alkaloids from Kopsia teoi , inhibitory potential against α-amylase, and their molecular docking studies

Monoterpenoid Indole Alkaloids From Kopsia Officinalis And The Immunosuppressive Activity Of Rhazinilam

New Barrigenol-Type Triterpenoids with Anti-Alzheimer's Disease Activity from Koelreuteria Paniculata Laxm.

Antifibrotic pyridine-containing monoterpene alkaloids from Caryopteris glutinosa

Total Synthesis of Kopsine, Fruticosine, and Structurally Related Polycyclic Caged Kopsia Indole Alkaloids

Dibenzocyclooctadiene lignans with antineurodegenerative potential from Kadsura ananosma

Tryptanthrin Analogs Substoichiometrically Inhibit Seeded and Unseeded Tau4RD Aggregation

Determination of Potential Lead Compound from Magnolia officinalis for Alzheimer's Disease through Pharmacokinetic Prediction, Molecular Docking, Dynamic Simulation, and Experimental Validation

Tetrahydroalstonine possesses protective potentials on palmitic acid stimulated SK-N-MC cells by suppression of Aβ1-42 and tau through regulation of PI3K/Akt signaling pathway

Antiproliferative Aspidosperma-Type Monoterpenoid Indole Alkaloids from Bousigonia mekongensis Inhibit Tubulin Polymerization

Novel 1,3,4-Thiadiazole/oxadiazole-linked Honokiol Derivatives Suppress Cancer Via Inducing PI3K/Akt/mTOR-dependent Autophagy

The IDO Inhibitor Coptisine Ameliorates Cognitive Impairment in a Mouse Model of Alzheimer's Disease.